U.S. copy of GSK's Advair a step closer as Mylan files generic version

U.S. copy of GSK's Advair a step closer as Mylan files generic version


Jan 12 The arrival of cheap generic versions of GlaxoSmithKline's top-selling lung drug Advair has moved a step closer with confirmation from Mylan that it has submitted a generic version for approval. Mylan said late on Monday it had filed an abbreviated new drug application to the U.S. Food and Drug Administration in December.



from Biotech News